| |
pre IVIG |
post I VIG |
p value |
| n |
14 |
|
| male, sex (%) |
8 (57.1%) |
|
| age (mo/o) |
34.3 (12~76, 26) |
|
| white blood cell counts (×103/μL) |
12.75±2.59 |
7.59±2.15 |
< 0.001 |
| peripheral neutrophils counts (/μL) |
7.09±2.50 |
2.11±0.77 |
0.008 |
| platelets counts (×103/μL) |
30.0±4.9 |
42.7±10.5 |
0.010 |
| C reactive protein (mg/dl) |
9.79±4.36 |
2.76±5.17 |
0.007 |
| serum albumin |
3.65±0.25 |
3.65±0.25 |
NS |
| aspartate amino transferase (U/L) |
122.4±127.4 |
50.6±30.9 |
NS |
| alanine aminotransferase (U/L) |
129.3±139.5 |
38.0±29.1 |
NS |
periods of administration of IVIG from
onset (days) |
4.9±0.9 |
|
| complication of coronary lesion |
1 (7.1%) |
|
| transient mild dilatation |
1 (7.1%) |
|
| aneurytm |
0 (0%) |
|